Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Aust Dent J ; 61(4): 446-454, 2016 12.
Article in English | MEDLINE | ID: mdl-26780408

ABSTRACT

BACKGROUND: Local anaesthetic-related systemic toxicity mainly results from elevated plasma concentrations of these drugs. We hypothesized that intraoral injection of submaximal doses of mepivacaine does not lead to toxic levels of this drug in blood. This study evaluated the plasma levels of mepivacaine in third molars surgeries. METHODS: Twenty-one patients were randomly assigned into two groups: group I (two unilateral third molars; submaximal dose of mepivacaine 108 mg with epinephrine 54 µg) and group II (four third molars; submaximal dose of mepivacaine 216 mg with epinephrine 108 µg). Blood samples were collected before anaesthesia, and 5, 10, 15, 20, 30, 40, 60, 90 and 120 min after anaesthesia. RESULTS: Individual peak plasma concentrations ranged 0.77-8.31 µg/mL (group I) and from 2.36-7.72 µg/mL (group II). An increase in the average dose of mepivacaine from 1.88 ± 0.12 mg/kg (group I) to 3.35 ± 0.17 mg/kg (group II) increased the mean mepivacaine peak plasma levels from 2.33 ± 0.58 to 4.01 ± 0.69 µg/mL, respectively. Four patients obtained plasma levels of mepivacaine above the threshold for toxicity (5 µg/mL). CONCLUSIONS: Toxic levels of mepivacaine are possible, even when a submaximal dose is used. A twofold increase in the dose of mepivacaine caused the mean peak plasma concentration to increase proportionally, indicating that they may be predicted based on the relation of dose per bodyweight.


Subject(s)
Anesthesia, Dental , Anesthetics, Local/administration & dosage , Mepivacaine/administration & dosage , Molar, Third/surgery , Adolescent , Adult , Anesthetics, Local/adverse effects , Anesthetics, Local/blood , Dose-Response Relationship, Drug , Epinephrine/administration & dosage , Epinephrine/adverse effects , Female , Heart Rate/drug effects , Humans , Injections , Male , Mepivacaine/adverse effects , Mepivacaine/blood , Molar, Third/diagnostic imaging , Young Adult
2.
Int J Oral Maxillofac Surg ; 44(9): 1166-74, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26144571

ABSTRACT

Pain after third molar extraction has been considered the most suitable pharmaceutical model to evaluate acute pain. This study aimed to evaluate the pre-emptive analgesic/anti-inflammatory efficacy of etoricoxib 120 mg following mandibular third molar surgery. A split-mouth, randomized, triple-blind, placebo-controlled study was conducted with patients undergoing the surgical removal of mandibular third molars. All volunteers were allocated randomly to receive either etoricoxib 120 mg or placebo 1h preoperatively, and inflammatory events were evaluated. An estimated sample of 18 surgical units per group was required based on a pilot study (95% confidence level and 80% statistical power). Rescue medication was analyzed by Kaplan-Meier method through log-rank Mantel-Cox test and Pearson linear correlation (P<0.05). Pre-emptive etoricoxib reduced postoperative pain scores significantly in comparison to placebo (P<0.001), with a pain score peak at 6h after surgery (P<0.001). The mean rescue medication consumption was lower in the etoricoxib group compared to the placebo group over the study period (P<0.05). There was no statistically significant difference between groups related to swelling and trismus. The pre-emptive administration of etoricoxib 120 mg significantly reduced the postoperative pain intensity and the need for rescue medication, but did not reduce swelling or trismus.


Subject(s)
Cyclooxygenase 2 Inhibitors/therapeutic use , Mandible/surgery , Molar, Third/surgery , Pain, Postoperative/prevention & control , Pyridines/therapeutic use , Sulfones/therapeutic use , Tooth Extraction , Tooth, Impacted/surgery , Adolescent , Adult , Double-Blind Method , Etoricoxib , Female , Humans , Male , Pain Measurement , Placebos , Treatment Outcome
3.
Int J Oral Maxillofac Surg ; 44(7): 876-84, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25847016

ABSTRACT

This study aimed to compare the effect of nimesulide and ketoprofen on inflammatory parameters related to the surgical removal of third molars. A split-mouth, prospective, randomized, double-blind study was conducted in patients undergoing removal of four third molars. Eighteen eligible patients were allocated to one of two groups to receive treatment two times a day with either ketoprofen 100 mg or nimesulide 100 mg for a period of 3 days. The rescue medication intake (number) and pain intensity were evaluated at 6, 12, 24, and 48 h, and at 7 days postoperatively. Swelling and maximum mouth opening were evaluated at 24 h, 72 h, and 7 days postoperatively. The peak pain score occurred at 6h after surgery in the nimesulide group and at 12h in the ketoprofen group. There was no statistically significant difference between the groups, although pain relief was observed after 48 h in the nimesulide group and after 7 days in the ketoprofen group. For each group, there was a statically significant difference in pain scores among the studied periods (P<0.0001). None of the patients required rescue medication. There was a statistically significant difference in maximum mouth opening between the preoperative and postoperative periods (P<0.0001). Ketoprofen and nimesulide were effective at controlling pain, swelling, and trismus after the surgical removal of third molars.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Calcium Channel Blockers/therapeutic use , Ketoprofen/therapeutic use , Molar, Third/surgery , Pain Management , Pain, Postoperative/drug therapy , Sulfonamides/therapeutic use , Tooth, Impacted/surgery , Adolescent , Adult , Double-Blind Method , Female , Humans , Male , Pain Measurement , Pilot Projects , Prospective Studies , Tooth Extraction , Treatment Outcome
4.
Int J Oral Maxillofac Surg ; 42(4): 474-80, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23158028

ABSTRACT

It has been suggested that third molars increase mandibular fragility because they do not contribute to its strength. For ethical reasons, a human study design that would permit the elucidation of this interference is not possible. This study evaluated the impact of the presence of erupted third molars on the mandibular angle of resistance when submitted to trauma. A three-dimensional (3D) mandibular model was obtained through finite element methodology using computed tomography (CT) with the geometry and mechanical properties to reproduce a normal mandibular structure. Human mandibles with no, one or two erupted third molars were evaluated. Whenever the third molar was present there was a greater concentration of tensions around the cervical part of its alveolus. Approximated Von Mises equivalent stress of the third molar region was 107.035 MPa in the mandible with teeth and 64.6948 MPa in the mandible without teeth. In the condylar region it was 151.65 MPa when the third molar was present and 184.496 MPa when it was absent. The digital models created proved that the mandibular angle becomes more fragile in the presence of third molars. When they are absent the energy concentrates on the lateral e posterior aspect of the condylar neck.


Subject(s)
Chin/injuries , Mandible/physiopathology , Mandibular Injuries/physiopathology , Molar, Third , Adult , Biomechanical Phenomena , Chin/diagnostic imaging , Chin/physiopathology , Computer Simulation , Cone-Beam Computed Tomography , Dental Stress Analysis , Finite Element Analysis , Humans , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Male , Mandible/diagnostic imaging , Mandibular Injuries/diagnostic imaging , Models, Biological , Molar, Third/diagnostic imaging
5.
Rev Stomatol Chir Maxillofac ; 112(5): 316-8, 2011 Nov.
Article in French | MEDLINE | ID: mdl-21924752

ABSTRACT

INTRODUCTION: Paranasal intra-sinus foreign bodies are often related to wounding agents or to penetrating trauma, as caused by car crashes. The maxillary sinus is the most often affected region. We present an atypical clinical case of a foreign body in the maxillary sinus. CASE REPORT: A 27-year-old male patient, consulted for right facial pain associated to a yellow and fetid nasal discharge. Tooth no. 16 had been extracted five months before. Twenty days after extraction, there was an oro-antral fistula which was closed with surgical dental cement. At consultation, the fistula was patent in the tooth alveolus. A "cone beam" CT scan showed a 2-cm long hyper dense image with well-defined margins within the right maxillary sinus, associated with sinusal mucosa thickening. The diagnosis was an oro-antral fistula complicated by maxillary sinusitis due to a foreign body. The foreign body was removed under general anesthesia and antibiotic therapy, through an antero-lateral antrotomy, and sinus curettage was performed. The anterior cortical wall was fixed with a titanium miniplate. The fistula was closed with a buccal fat pad. There was no complication during the 24-month follow-up. DISCUSSION: Foreign bodies may be found in the sinuses, especially in the maxillary sinus. They are often of iatrogenic origin. CT scan may confirm the diagnosis. The treatment is surgical removal.


Subject(s)
Foreign Bodies/diagnosis , Maxillary Sinus , Wound Closure Techniques/adverse effects , Adult , Foreign Bodies/surgery , Humans , Male , Maxillary Sinus/pathology , Maxillary Sinus/surgery , Maxillary Sinusitis/diagnostic imaging , Maxillary Sinusitis/etiology , Maxillary Sinusitis/surgery , Paranasal Sinuses/diagnostic imaging , Paranasal Sinuses/surgery , Radiography
6.
Med Oral Patol Oral Cir Bucal ; 16(5): e657-63, 2011 Aug 01.
Article in English | MEDLINE | ID: mdl-20711126

ABSTRACT

OBJECTIVE: The purpose of this study is to estimate how is the magnitude of the impact of a mandibular third molar on the mandibular angle stiffness. STUDY DESIGN: It was performed a literature search on whole MEDLINE and LILACS data base to find articles that match the following inclusion criteria: cohort studies presenting data on patients with mandibular fractures and third molars; that had a similar angle fracture definition; and that present data available to be cross-classified in a statistic analysis. RESULTS: The sample was composed by 4 studies, involving 2533 patients from USA, Nigeria, Germany and Jordan, evaluated between 1976 and 2001. The analysis of the sample shows a relative risk for a mandibula to fracture, comparing patients with and without third molars, ranging from 1,18 to 2,25. The data of the sample was grouped because of the homogeneity of the articles methods. The estimated relative risk across the 4 studies was 1,94 (95% CI 1,6 - 2,35). CONCLUSIONS: The presence of a third molar may double the risk of an angle fracture of the mandible to occur. Even with this data, the present study cannot support conditions related to the third molar that may affect this impact. Further studies are necessary to discuss the true indication of removal of these teeth as a prophylactic measure in population groups more predisposed to fracture.


Subject(s)
Mandibular Fractures/etiology , Molar, Third , Humans , Mandible/physiopathology , Risk Factors
7.
Trop Doct ; 41(1): 61-2, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21109606

ABSTRACT

Myiasis is a type of infection caused by the larvae of flying insects. This paper reports a case of a 72-year-old Caucasian man who was referred to the Infectology Department of Oswaldo Cruz University Hospital (Pernambuco-Brazil) for urgent treatment as he was malnourished and dehydrated. He had a facial and buccal lesion colonized with larvae and was extremely debilitated. The surgical and clinical treatment indicated at the first moment was the surgical removal of the larvae. But, after two days, some larvae were still present and therefore 12 mg of ivermectin was administered. At the end of the treatment, 601 larvae had been removed and the therapeutics established were suitable.


Subject(s)
Diptera/growth & development , Diptera/pathogenicity , Mouth Diseases/pathology , Mouth Diseases/parasitology , Myiasis/pathology , Aged , Animals , Antiparasitic Agents/therapeutic use , Brazil , Humans , Ivermectin/therapeutic use , Larva/pathogenicity , Male , Mouth Diseases/drug therapy , Mouth Diseases/surgery , Myiasis/drug therapy , Myiasis/parasitology , Myiasis/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...